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Abstract
Heterozygous mutations of the Forkhead-box protein 2 (FOXP2) gene in humans cause childhood apraxia of speech. Loss of 
Foxp2 in mice is known to affect striatal development and impair motor skills. However, it is unknown if striatal excitatory/
inhibitory balance is affected during development and if the imbalance persists into adulthood. We investigated the effect of 
reduced Foxp2 expression, via a loss-of-function mutation, on striatal medium spiny neurons (MSNs). Our data show that 
heterozygous loss of Foxp2 decreases excitatory (AMPA receptor-mediated) and increases inhibitory (GABA receptor-medi-
ated) currents in D1 dopamine receptor positive MSNs of juvenile and adult mice. Furthermore, reduced Foxp2 expression 
increases GAD67 expression, leading to both increased presynaptic content and release of GABA. Finally, pharmacological 
blockade of inhibitory activity in vivo partially rescues motor skill learning deficits in heterozygous Foxp2 mice. Our results 
suggest a novel role for Foxp2 in the regulation of striatal direct pathway activity through managing inhibitory drive.
Keywords Foxp2 · Excitatory-inhibitory balance · Neurodevelopment · D1R-MSN · Striatum
Introduction
Balanced neuronal activity between cortex, striatum and 
thalamus is essential for the generation of voluntary move-
ments (Shepherd 2013). Imbalanced activity within the stria-
tum is known to disrupt complex motor behaviors, such as 
the production of spoken language (Peach 2004; Square-
Storer et al. 1990). FOXP2, the first single gene linked to a 
speech and language disorder (Lai et al. 2001), is important 
for the correct execution of complex motor behaviors used 
for speech. Individuals with mutations in the FOXP2 gene 
have problems executing coordinated sequences of orofa-
cial movements, which impede their speech [diagnosed as 
developmental verbal dyspraxia or childhood apraxia of 
speech (CAS)], while their general cognitive functioning 
and other aspects of motor coordination are usually less 
severely affected (MacDermot et al. 2005; Morgan et al. 
2017). Mice with heterozygous Foxp2 mutations display 
impairments in motor skill learning, shown by decreased 
performance on the accelerating rotarod (French et al. 2012; 
Groszer et al. 2008), suggesting that similar neurobiologi-
cal substrates could underlie the behavioral phenotypes in 
human and mouse. FoxP2 codes for a transcription factor 
(Devanna et al. 2014; Vernes et al. 2006, 2007) and plays 
important roles during the early development of the central 
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nervous system as well as in the postnatal brain (Spiteri et al. 
2007; Vernes et al. 2011; Groszer et al. 2008). Mutations of 
this gene affect both cortical and striatal activity in human 
cases and animal models (French et al. 2012; Groszer et al. 
2008; Liegeois et al. 2003). Of particular note, striatal long-
term depression is affected in adult mice with heterozygous 
Foxp2 mutations (Groszer et al. 2008; Enard et al. 2009), 
which suggests that Foxp2 regulates molecular mechanisms 
involved in synaptic plasticity. Additionally, evidence from 
in vivo recordings shows that Foxp2 mutant mice display 
abnormal ongoing striatal activity and dysregulated firing 
rates during a motor-learning task (French et al. 2012). 
Finally, Foxp2 has been reported to regulate genes involved 
in synapse formation (Sia et al. 2013; Vernes et al. 2011) 
and was recently shown to affect excitatory synaptic activity 
during early postnatal development through inhibition of the 
Mef2c gene (Chen et al. 2016).
Studies using mouse models to investigate the functions 
of Foxp2 have made use of two well described mutations 
which differentially affect Foxp2 and are similar to muta-
tions described in patients with CAS. These mutations 
lead to either disruption of the DNA binding domain of 
Foxp2, or a loss of function stop-gain mutation in exon 
7 that causes nonsense mediated decay of Foxp2 protein 
(MacDermot et al. 2005; Morgan et al. 2017). Though neu-
robiological mechanisms affected by these different muta-
tions could differ, there is currently no data to suggest this. 
Moreover, heterozygous Foxp2 mice with either the DNA 
binding domain mutation or the loss of function mutation 
display similar impairments in motor skill learning (French 
et al. 2012; Enard et al. 2009; Groszer et al. 2008).
To date, investigations into the functions of Foxp2 in 
striatum have focused on how Foxp2 affects excitatory 
activity (Groszer et al. 2008; Enard et al. 2009; French et al. 
2012; Chen et al. 2016; Schreiweis et al. 2014). Although 
the striatum receives numerous excitatory connections from 
the cortex (Shepherd 2013) and thalamus (Smith et al. 2004, 
2009), it is itself entirely composed of inhibitory neurons 
(Kreitzer and Malenka 2008). GABAergic medium spiny 
neurons (MSNs) make up 95% of the striatum, and two 
major populations can be distinguished: MSNs that express 
either the D1 dopamine receptor (D1R-MSNs) or the D2 
dopamine receptor (D2R-MSNs) (Gittis and Kreitzer 2012). 
These MSN populations differentially affect the downstream 
neural sites to which they ultimately project, and each reg-
ulate separate aspects of motor behavior (Calabresi et al. 
2014; Surmeier et al. 2007; Gittis and Kreitzer 2012). D1R-
MSNs innervate the direct pathway, which leads to increased 
activation of the cortico-striatal-thalamic motor circuit. In 
contrast, D2R-MSNs belong to the indirect pathway, inacti-
vating this motor circuit. Balanced excitation and inhibition 
(E/I balance) of cells within both striatal pathways is crucial 
for the generation of complex motor behaviors (Schroll et al. 
2015).
How Foxp2 affects neuronal function has been investi-
gated in both early development and adulthood, but knowl-
edge of how Foxp2 affects striatal circuits during (motor) 
development is lacking. This is especially important to 
address since E/I balance is dynamic. Changes in E/I bal-
ance during development are tightly regulated and have been 
described in multiple cell types in hippocampus (Liu 2004) 
and cortex (Zhang et al. 2011) of juvenile mice. A disrupted 
E/I balance during development can severely affect adult 
behavior (Peixoto et al. 2016). Indeed, aberrant E/I balance 
in striatal cells is known to lead to impaired motor learning 
in adult mice (Rothwell et al. 2014), similar to the deficits 
observed in adult mice with mutations in Foxp2 (French 
et al. 2012; Groszer et al. 2008).
We examined the effects of reduced Foxp2 expression 
from early development into adulthood in the striatum, 
using a heterozygous mouse model for the stop-gain Foxp2 
mutation (S321X). Foxp2 protein expression is absent in 
Foxp2S321X/S321X mice and reduced to intermediate levels in 
Foxp2S321X/+mice (Groszer et al. 2008; Vernes et al. 2011). 
We provide evidence that Foxp2 plays a role in the regulation 
of striatal E/I balance, regulates inhibitory activity through 
repression of GAD67, and regulates inhibitory presynap-
tic strength of D1R-MSNs, but not D2R-MSNs. Finally, we 
show that pharmacological blockade of striatal inhibition 
partially rescues the motor skill learning deficits observed in 
heterozygous Foxp2 mutant mice. Taken together, our results 
reveal a developmental circuit defect caused by reduced lev-
els of functional Foxp2, which suggests that E/I imbalances 
in striatal activity may contribute to (vocal) motor problems 
in humans with FOXP2 mutations.
Results
Reduced Foxp2 expression affects D1R‑MSN 
excitatory synaptic inputs
Previous studies have suggested that Foxp2 is differentially 
expressed in D1R- versus D2R-expressing MSNs in the stri-
atum (Vernes et al. 2011). To directly assess the expression 
of Foxp2 in D1R- and D2R-MSNs, we performed immu-
nocytochemistry for Foxp2 on mice containing bacterial 
artificial chromosome (BAC)-TRAP GFP constructs (Hei-
man et al. 2008; Doyle et al. 2008) under the D1R or D2R 
promoter, which have been shown to faithfully label D1R- or 
D2R-expressing MSNs, respectively (Heiman et al. 2008). 
Upon investigation of expression in juvenile mice (PND11-
14) we found that Foxp2 is expressed in nearly all striatal 
D1R-MSNs, in contrast to only a small fraction of D2R-
MSN (Fig. 1a).
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We next investigated whether heterozygous Foxp2 loss 
of function differentially affects striatal MSN subtypes at 
the synaptic level. To enable a targeted single-cell charac-
terization of how reduced Foxp2 expression affects striatal 
activity, we crossed Foxp2S321X/+ mice with (BAC)-TRAP 
D1R-GFP mice. We performed patch-clamp recordings 
on GFP-positive D1R-MSNs and non-GFP putative D2R-
MSNs. Although Foxp2 expressing MSNs are spread 
throughout the striatum, we chose to focus on cells in 
the dorsolateral striatum, because of its connection to the 
motor cortex (Hunnicutt et al. 2016). Moreover, previous 
experiments regarding Foxp2 function have shown aberrant 
activity in dorsal striatum of heterozygous Foxp2 mutant/
knockout mice (French et al. 2012; Groszer et al. 2008; 
Reimers-Kipping et  al. 2011), and reduced motor skill 
learning suggests areas involved in motor control might be 
more severely affected by reduced Foxp2 expression. We 
measured excitatory synaptic strength through glutamater-
gic α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic 
acid (AMPA) receptor activation by analysis of minia-
ture excitatory postsynaptic current (mEPSC) amplitude 
and frequency. In D1R-MSNs of heterozygous postnatal 
day (PND) 10–14 juvenile mice, mEPSC amplitude was 
reduced, whereas mEPSC frequency was similar between 
genotypes (Fig. 1c). No changes in D2R-MSN amplitude 
or frequency were observed (Fig. 1d). Finally, we measured 
AMPA/NMDA ratio in D1R-MSNs of juvenile Foxp2+/+ 
and Foxp2S32X/+ mice. AMPA/NMDA ratio is significantly 
increased in Foxp2S32X/+ mice, which suggests that NMDA 
currents are decreased as well in addition to the previously 
observed reduction in AMPAR-mediated activity (Suppl 
Fig. 1). These results show that reduced Foxp2 expression 
leads to decreased excitatory postsynaptic strength of only 
direct pathway MSNs, which is consistent with the predomi-
nant expression of Foxp2 in D1R-MSNs.
Inhibitory synaptic inputs are increased 
in D1R‑MSNs of Foxp2S321X/+ mice
Physiological effects of heterozygous Foxp2 mutations have 
only been investigated in the context of excitatory synap-
tic transmission (Chen et al. 2016; Reimers-Kipping et al. 
2011; Schreiweis et al. 2014). Since E/I balance is impor-
tant for the development and maintenance of neuronal cir-
cuitry, we examined the role of Foxp2 in striatal inhibition. 
Striatal inhibition is accomplished through extra-striatal as 
well as intra-striatal sources. From the cortex, GABAergic 
interneurons project to the striatum and provide inhibitory 
input (Melzer et al. 2017). However, corticostriatal GABAe-
rgic interneurons do not express Foxp2 (Chiu et al. 2014; 
Hisaoka et al. 2010). We, therefore, expect differences in 
inhibitory activity between wild-type and Foxp2S321X/+ 
mice through changes in intra-striatal inhibition, which is 
regulated through MSNs and striatal interneurons (Taverna 
et al. 2008; Lalchandani and Vicini 2013). We measured 
inhibitory activity only in D1R-MSNs, since unidirectional 
connections between D1R-MSNs are common, while con-
nections between D1R-MSNs and D2R-MSNs are rare (6%) 
(Taverna et al. 2008). Though D2R-MSNs synapse on D1R-
MSNs (27%) the lack of Foxp2 expression in D2R-MSNs, 
combined with the lack of an excitatory phenotype, suggests 
that D2R-MSNs cannot be cell-autonomously affected by 
Foxp2.
We measured miniature inhibitory postsynaptic currents 
(mIPSCs), which are mediated by GABA and reflect inhibi-
tory synaptic strength. In D1R-MSNs of juvenile (PND10-
14) Foxp2S321X/+ mice, we found that mIPSC amplitude and 
frequency were increased compared to wild-type controls 
(Fig. 1e). Our data show that reduced Foxp2 expression dif-
ferentially affects excitatory and inhibitory synaptic strength. 
There is no compensation for the decreased excitatory activ-
ity, but rather this is aggravated by increased inhibition.
E/I imbalance persists in dorsolateral striatum 
of adult Foxp2S321X/+ mice
In mice, Foxp2 is present during the entire lifespan (Fer-
land et al. 2003), and expression does not change strongly 
between juvenile and adult animals (Ferland et al. 2003; 
Takahashi et al. 2003). However, given that this gene is 
important for early neuronal development (Vernes et al. 
2011; Chen et al. 2016), it is conceivable that functional 
effects of reduced Foxp2 expression differ between juve-
nile and adult animals. In previous studies the effects of 
Foxp2 mutations on striatal physiology have only been 
investigated in adult (French et al. 2012; Groszer et al. 
2008) or juvenile mice separately (Chen et al. 2016), and 
thus a developmental profile of synaptic changes due to 
reduced Foxp2 expression is lacking. We hypothesized 
that the E/I imbalance present in D1R-MSNs of juvenile 
Foxp2S321X/+ mice might persist until adulthood, since adult 
Foxp2 heterozygous mice show clear deficits in motor skill 
learning. We measured the GABA/AMPA ratio as an index 
of E/I balance in juvenile PND11, PND14, PND17 as well 
as adult (PND60) mice, which comprises a developmen-
tal profile at ages around the critical time points for the 
emergence of motor coordination (Dehorter et al. 2011) 
and striatal synaptic integration and circuit formation in 
mice (Lee and Sawatari 2011). During development in 
wild type mice, the GABA/AMPA ratio increases sharply 
in D1R-MSNs (Fig. 2a). Interestingly, both during devel-
opment and in adulthood the GABA/AMPA ratio of D1R-
MSNs was significantly higher in Foxp2S321X/+ mice than 
in wild-type controls (Fig. 2a), which indicates that the 
E/I imbalance we uncovered in juvenile mice indeed per-
sists into adulthood. We subsequently measured mEPSCs 
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and mIPSCs in D1R-MSNs of adult (PND60) Foxp2S321X/+ 
mice to determine if the increased GABA/AMPA ratios in 
Foxp2S321X/+ mice reflect persistent changes in excitatory 
and/or inhibitory synaptic strength. Our results show that 
the increased GABA/AMPA ratio in adult heterozygous 
mice is due to decreased mEPSC amplitude (Fig. 2b) cou-
pled with an increased mIPSC amplitude (Fig. 2c). How-
ever, the increased mIPSC frequency we had observed in 
our juvenile mice was not present in adult mice (Fig. 2c), 
which indicates that some form of compensation might 
be present. This compensation is, however, insufficient to 
return activity to baseline levels and, therefore, we con-
clude that the changes in E/I balance are persistent into 
adulthood. Changes in inhibitory synaptic strength can 
indicate changes at either the pre- or the post-synapse, 
such as increased presynaptic neurotransmitter release or 
increased expression of postsynaptic GABA receptors, 
respectively. We, therefore, set out to assess the effect 
of reduced Foxp2 expression on striatal synapses at the 
molecular level.
Decreased Foxp2 expression leads to increased 
GAD67 expression around D1R‑MSN somata
Foxp2 might modulate inhibitory activity by transcription-
ally regulating genes involved in GABA signaling (Vernes 
et al. 2007, 2011; Fujita et al. 2008). One target gene identi-
fied in an in vivo chromatin immunoprecipitation (ChIP)-
chip screen for Foxp2 binding in mouse brain was Gad 
(Vernes et al. 2011), the gene that codes for GAD67, a key 
enzyme in the production of GABA at the synapse (Lau and 
Murthy 2012). By contrast, other genes involved in GABAe-
rgic activity, such as VGAT or GAD2, were not detected 
in this ChIP screen. Moreover, GAD2 expression has been 
shown to be unaltered in striatal tissue from Foxp2 hete-
rozygous knockout embryos (French et al. 2007). Based on 
these findings we hypothesized that reduced Foxp2 expres-
sion could lead to changes in GAD67 expression, and thus 
contribute to aberrant GABAergic activity.
We compared GAD67 expression around D1R-MSN 
somata in the striatum of juvenile Foxp2+/+ and Foxp2S321X/+ 
mice (Fig. 3a). GAD67 puncta surrounding striatal D1R-
MSNs originate mostly from D1R-MSN to D1R-MSN pairs 
(Taverna et al. 2008) and to a lesser extent from extrastriatal 
GABAergic interneurons (Melzer et al. 2017) and striatal 
interneurons (Taverna et al. 2008). However, of these cells 
only D1R-MSNs express Foxp2 (Fong et al. 2018). Thus, 
aberrant GAD67 expression levels can be related to changes 
in Foxp2 expression. This could either be through direct reg-
ulation of GAD67 expression by Foxp2 or by indirect effects 
of altered Foxp2 levels. Foxp2 is known to affect the devel-
opment of striatal cells in primary cell culture (Vernes et al. 
2011) and impaired D1R-MSN development in vivo may 
account for changes in protein expression, such as reduced 
GAD67 levels. We found that GAD67 expression was signif-
icantly increased around D1R-MSN somata in Foxp2S321X/+ 
mice compared to wild-type controls (Fig.  3b), whilst 
GAD67 was not changed around D2R-MSNs (Suppl Fig. 2). 
Furthermore, protein expression analysis by western blot in 
dissected striatum from juvenile Foxp2+/+ and Foxp2S321X/+ 
mice showed GAD67 expression to be increased (Fig. 3c).
To assess whether or not the increased GAD67 expres-
sion could be due to a general increase in expression of key 
components of GABA transmission, we quantified vesic-
ular GABA transporter (VGAT) expression around D1R-
MSN somata (Fig. 3a). No change in VGAT expression was 
observed between Foxp2+/+ and Foxp2S321X/+ mice, which 
suggests that Foxp2 specifically regulates GAD67 but does 
not affect the number of synapses. The increase in GAD67 
levels of mice with reduced Foxp2 expression is consist-
ent with the hypothesis that Foxp2 normally acts to repress 
the transcription of Gad1 and is supported by the prior 
ChIP–chip data (Vernes et al. 2011). Differences in GAD67 
expression have been described as a cause for changes in 
presynaptic GABA content and inhibitory activity (Lau 
and Murthy 2012). Thus, reduced Foxp2 expression could 
lead to increased inhibitory drive of D1R-MSNs through 
increased GABA production.
Fig. 1  Foxp2 is predominantly expressed in D1R-MSNs in dor-
solateral striatum and affects synaptic activity. a D1R-GFP, 
D2R-GFP and Foxp2 are expressed in a subset of striatal cells 
in juvenile (PND11-14) mice, arrows point to cells with over-
lapping D1R and Foxp2 expression (top row) or D2R expres-
sion without Foxp2 expression (bottom row). Scale bar 50  µm. 
b 83.7 ± 16% of D1R-GFP positive cells express Foxp2, com-
pared to 16.9 ± 4% of D2R-GFP cells. N/n number of mice/num-
ber of slices. N/n = 3/12. c Striatal D1R-MSN mEPSC amplitude 
is decreased following reduced Foxp2 expression. Example of 
mEPSC activity in striatal D1R-MSNs from juvenile (PND14) 
Foxp2+/+ and Foxp2S321X/+ mice. Scale bar 200  ms/20  pA. Cumula-
tive distribution of mEPSC amplitude (Foxp2+/+ = 19.4 ± 0.69  pA, 
Foxp2S321X/+ = 14.3 ± 0.36 pA, P < 0.0001) and frequency 
(Foxp2+/+ = 1.12 ± 0.1  Hz, Foxp2S321X/+ = 1.19 ± 0.11  Hz, NS) in 
striatal D1R-MSNs. Foxp2+/+ N/n = 3/31, Foxp2S321X/+ N/n = 3/32. 
d Example traces of mEPSC activity in striatal D2R-MSNs from 
juvenile (PND14) Foxp2+/+ and Foxp2S321X/+ mice Scale bar 
200  ms/20  pA. Cumulative distribution of mEPSC amplitude 
(Foxp2+/+ = 15.64 ± 0.53 pA, Foxp2S321X/+ = 16.14 ± 0.62 pA, NS) and 
frequency (Foxp2+/+ = 0.92 ± 0.12  Hz, Foxp2S321X/+ = 0.89 ± 0.1  Hz, 
NS) in striatal D2R-MSNs. Foxp2+/+ N/n = 3/22, Foxp2S321X/+ 
N/n = 3/19. e Example traces of mIPSC activity in striatal D1R-
MSNs from juvenile (PND14) Foxp2+/+ and Foxp2S321X/+ mice. 
Scale bar 200  ms/10  pA. Cumulative distribution of mIPSC ampli-
tude (Foxp2+/+ = 8.6 ± 0.27  pA, Foxp2S321X/+ = 11.9 ± 0.83  pA, 
P < 0.001) and frequency (Foxp2+/+ = 0.18 ± 0.036  Hz, 
Foxp2S321X/+ = 0.71 ± 0.14  Hz, P < 0.01) in striatal D1R-MSNs. 
Foxp2+/+ N/n = 3/20, Foxp2S321X/+ N/n = 3/17. ***P < 0.01. N number 
of mice, n number of cells. All data analyzed by two-sided Students’ 
T test
◂
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Fig. 2  Decreased excitation and increased inhibition persist in adult 
mice with decreased Foxp2 expression. a Example traces show 
AMPA response (negative) and GABA response (positive) in D1R-
MSNs of Foxp2+/+ and Foxp2S321X/+ mice during development and 
in adulthood. Scale bar 200/50  pA. GABA/AMPA ratio in D1R-
MSNs of Foxp2+/+ (PND11 = 0.32 ± 0.037, PND14 = 0.29 ± 0.035, 
PND17 = 0.50 ± 0.077, PND60 = 2.04 ± 0.47) and Foxp2S321X/+ 
(Foxp2S321X/+ PND11 = 0.53 ± 0.049, PND14 = 0.6 ± 0.078, 
PND17 = 0.94 ± 0.12, PND60 = 4.5 ± 0.85), mice during develop-
ment and in adulthood (2-factor ANOVA (genotype × age) = P < 0.001 
for both factors). N number of mice, n number of cells. Foxp2+/+ 
N/n = 3/31 (PND11), 3/26 (PND13), 3/14 (PND17), 3/18 (PND60), 
Foxp2S321X/+ N/n = 3/31 (PND11), 3/26 (PND13), 3/15 (PND17), 
3/17 (PND60). b Example traces of mEPSC activity in striatal D1R-
MSNs from adult (PND60) Foxp2+/+ and Foxp2S321X/+ mice. Cumu-
lative distribution of mEPSC amplitude (Foxp2+/+ = 12.9 ± 0.64 pA, 
Foxp2S321X/+ = 10.2 ± 0.4 pA, P < 0.01, two-sided Student’s T test) and 
frequency (Foxp2+/+ = 1.68 ± 0.16  Hz, Foxp2S321X/+ = 1.42 ± 0.2  Hz, 
NS, two-sided Student’s T test) in striatal D1R-MSNs. Foxp2+/+ 
N/n = 3/13, Foxp2S321X/+ N/n = 3/12. c Example traces of mIPSC 
activity in striatal D1R-MSNs from adult (PND60) Foxp2+/+ and 
Foxp2S321X/+ mice. Cumulative distribution of mIPSC amplitude 
(Foxp2+/+ = 11.36 ± 0.41 pA, Foxp2S321X/+ = 12.9 ± 0.82 pA, P < 0.01, 
two-sided Student’s T test) and frequency (Foxp2+/+ = 0.67 ± 0.07 Hz, 
Foxp2S321X/+ = 0.81 ± 0.09 Hz, NS, two-sided Student’s T test) in stri-
atal D1R-MSNs. Foxp2+/+ N/n = 4/11, Foxp2S321X/+ N/n = 6/19. Scale 
bar in b, c 200 ms/10 pA. ***P < 0.001
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Fig. 3  Increased GAD67 expression in Foxp2S321X/+ mice (ai, aii). 
Overview of GAD67 and VGAT expression levels in striatal slices 
of juvenile (PND10-14) Foxp2+/+ and Foxp2S321X/+ mice. Insets 
show puncta which surround D1R-MSN somata. These periso-
matic puncta were used for intensity analysis, to restrict analysis to 
D1R-MSNs. b Comparison of GAD67 expression (both cumula-
tive distribution in arbitrary units (AU) and normalized expression) 
around D1R-GFP positive somata in dorsolateral striatum of juvenile 
(PND10-14) Foxp2+/+ and Foxp2S321X/+ mice. All data were com-
pared to normalized expression levels in Foxp2+/+ mice. (Foxp2S321X/+ 
1.32 ± 0.12, P < 0.01, Mann–Whitney U). Kolmogorov–Smirnov 
(KS) test was used for the cumulative distribution data, P < 0.001. 
Foxp2+/+ N/n = 5/36, Foxp2S321X/+ N/n = 5/36. c Quantification and 
representative western blot of GAD67 protein expression in juvenile 
Foxp2+/+ and Foxp2S321X/+ mice (Foxp2+/+ 1.04 ± 0.05, Foxp2S321X/+ 
1.28 ± 0.04, P < 0.01, two-sided Student’s T test. Foxp2+/+ and 
Foxp2S321X/+ N = 6). d Comparison of VGAT expression [both cumu-
lative distribution in arbitrary units (AU) and normalized expres-
sion] around D1R-GFP positive somata in dorsolateral striatum of 
juvenile (PND10-14) Foxp2+/+ and Foxp2S321X/+ mice. Foxp2S321X/+ 
0.97 ± 0.07, NS, Mann–Whitney U. KS test for cumulative dis-
tribution data: NS. Foxp2+/+ N/n = 3/12, Foxp2S321X/+ N/n = 3/12. 
N/n: number of animals/number of slices *P < 0.05, **P < 0.01, 
***P < 0.001
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Presynaptic GABA content is increased 
upon heterozygous loss of Foxp2 function
As GAD67 levels directly correlate with presynaptic GABA 
production, we explored if the increased GAD67 levels fol-
lowing reduced Foxp2 expression lead to elevated presyn-
aptic GABA concentration. Presynaptic GABA is stored 
in vesicles, and is released upon electrical or pharmaco-
logical stimulation of the neuron (Alabi and Tsien 2012). 
A 10 s 10 Hz stimulation protocol has been described that 
efficiently depletes the entire readily releasable GABA 
vesicle pool (RRP) (Maas et al. 2017; Chen et al. 2017). 
This depletion protocol can be used to compare the quantal 
content of the GABA RRP between D1R-MSNs of wild-
type and Foxp2S321X/+ mice. We show that this stimulation 
protocol indeed depletes the RRP in juvenile wild-type and 
Foxp2S321X/+ mice (Fig. 4a, b). However, in Foxp2S321X/+ 
mice the average current transferred per stimulation, as well 
as the cumulative current transferred after 100 stimulations, 
was significantly increased compared to wild-type controls 
(Fig. 4c). However, we did not observe a difference in the 
kinetics of release when release was normalized, which indi-
cates that vesicle recycling was not affected in Foxp2S321X/+ 
mice (Fig. 4b).
Changes in GABA concentration at the synapse can 
affect synaptic strength and vesicle release probability (Olpe 
et al. 1994; Jensen et al. 1999). We, therefore, examined 
both excitatory and inhibitory paired pulse ratios (PPRs) in 
juvenile  Foxp2S321X/+ mice and littermate controls. No dif-
ferences in excitatory PPRs were found between genotypes 
(Fig. 4d). However, in contrast to the expected increase in 
inhibitory PPR  Foxp2S321X/+ mice showed a lack of inhibi-
tory paired pulse depression, specifically at longer inter 
stimulus intervals (Fig. 4e). The lack of inhibitory PPD 
can be explained increased GABA release per stimulation 
(Fig. 4a). If only a fraction of the total released GABA is 
necessary to saturate postsynaptic GABA, then reduction 
of vesicles released with subsequent stimulations would 
not lead to PPD, because enough GABA is still released to 
saturate the postsynaptic GABA receptors that are present.
Next, we sought to confirm the increased presynaptic 
GABA release pharmacologically, to exclude aberrant effects 
from recurrent stimulation. Local application of 500 mM 
sucrose for 10 s (Lipstein et al. 2017) efficiently induced ves-
icle exocytosis in juvenile Foxp2+/+ and Foxp2S321X/+ mice 
(Fig. 4f). The total current transfer during sucrose appli-
cation was increased by approximately 50% in D1R-MSNs 
from Foxp2S321X/+ mice, similar to the increase in current 
transfer observed upon electrical stimulation (Fig. 4f).
Finally, the increase in mIPSC amplitude (Figs. 2b, 3h) 
in mice with reduced Foxp2 expression also suggests post-
synaptic GABA receptor abundance might be increased. We 
used local application of GABA to investigate if postsynaptic 
 GABAA receptor presence was affected by reduced Foxp2 
expression. GABA application elicited a strong response 
in D1R-MSNs of both Foxp2+/+ and Foxp2S321X/+ mice 
(Fig. 4g). No difference in peak response amplitude or 
total current transfer could be observed between genotypes 
(Fig. 4g). Taken together, our data suggest that D1R-MSNs 
exhibit increased GABA content at the presynapse following 
reduced Foxp2 expression, leading to a heightened quantal 
GABA release. This in turn leads to elevated inhibition of 
the striatal direct pathway.
Pharmacological manipulation of inhibition 
partially rescues motor skill learning deficits 
in Foxp2S321X/+ mice
Because aberrant regulation of direct pathway inhibitory 
activity has been shown to produce motor skill learning 
deficits (Rothwell et al. 2014; Zhang et al. 2015), we next 
investigated whether blocking inhibitory activity might be an 
effective in vivo intervention. One of the most pronounced 
behavioral deficits displayed by mice with heterozygous 
mutations in Foxp2 is decreased motor skill learning, shown 
by impaired performance on the accelerating rotarod (Gro-
szer et al. 2008; French et al. 2012). Increased inhibition of 
the direct pathway as demonstrated herein could help explain 
why Foxp2 mutations lead to impaired rotarod performance, 
since successful acquisition of this task is dependent on pre-
cise regulation of striatal activity. Cui et al. (2008) showed 
that increases in presynaptic GABA content cause learning 
and memory deficits when present in hippocampal neurons. 
Intriguingly, they found that learning and memory improved 
dramatically after a low concentration intraperitoneal (IP) 
injection with picrotoxin (PTX), a compound that blocks 
 GABAA receptor mediated inhibition (Cui et al. 2008). We, 
therefore, hypothesized that a low dose of PTX might be 
able to ameliorate the motor skill learning deficits present 
in the Foxp2S321X/+ mice in a similar manner.
We first validated the presence of motor skill learn-
ing deficits in our Foxp2S321X/+ mice by measuring their 
performance and learning rate on the accelerating rotarod 
during five consecutive training days and comparing them 
to littermate controls (Fig. 5a, b). The impaired rotarod 
performance in adult Foxp2S321X/+ mice that we observed 
is consistent with previous reports on Foxp2 heterozygous 
mutant mice (French et al. 2012; Groszer et al. 2008). 
Next, we assessed a viable treatment dose. Injection 
of 1 mg/kg PTX produced grand mal seizures in both 
Foxp2+/+ and Foxp2S321X/+ mice, whereas both 0.01 mg/kg 
and 0.05 mg/kg did not have any effect on rotarod perfor-
mance (Suppl. Figure 3). An intermediate dose of 0.1 mg/
kg did not induce seizures, but had a notable negative 
effect on the rotarod performance of pre-trained wild-type 
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mice (Suppl. Figure 4), whereas the rotarod performance 
of pre-trained heterozygous mice was not affected.
We, therefore, injected wild-type and Foxp2S321X/+ mice 
with 0.1 mg/kg PTX 10 min prior to each training session 
and subjected them to the same motor learning paradigm 
as the vehicle-injected (DMSO) mice. Interestingly, this 
a
Foxp2 +/+
Foxp2 S321X/+
b c
e
f
***
g
*
***
***
d
Fig. 4  Presynaptic GABA content in juvenile (PND10-14) striatal 
D1R-MSNs is increased upon decreased Foxp2 expression. a Exam-
ple traces of vesicle depletion following train stimulation (10  Hz, 
100 stimuli) in Foxp2+/+ and Foxp2S321X/+ D1R-MSNs, every 10th 
response is shown. Scale 100 ms/50 pA. b Normalized (to first pulse) 
IPSC response during train stimulation. c Cumulative IPSC ampli-
tude during train stimulation of D1R MSNs, (Foxp2+/+ = intercept 
294.24 ± 85.3 pA, cumulative 3112.9 ± 286.4 pA, Foxp2S321X/+ = inter-
cept 498.9 ± 301.3 pA, cumulative 5142.1 ± 484.6  pA, P < 0.001, 
two-sided Student’s T test). N number of mice, n number of cells. 
Foxp2+/+ N/n = 3/16, Foxp2S321X/+ N/n = 3/16. d Example trace of 
excitatory PPR at different inter stimulus intervals (ISI) in D1R-MSNs 
of Foxp2+/+ and Foxp2S321X/+ mice. Scale 100 ms/50 pA. Quantifica-
tion of paired pulse ratio (PPR) (50, 100, 150, 200, 500ms: Foxp2+/+ 
1.573 ± 0.08, 1.284 ± 0.06, 0.958 ± 0.02, 0.955 ± 0.04, 0.856 ± 0.02 
vs Foxp2S321X/+ 1.864 ± 0.13, 1.357 ± 0.1, 1.244 ± 0.1, 1.131 ± 0.06, 
0.884 ± 0.04, NS, Repeated measures ANOVA). Foxp2+/+ N/n = 2/8, 
Foxp2S321X/+ N/n = 3/11. e Same as d but for inhibitory PPR, 
(50, 100, 150, 200, 500  ms: Foxp2+/+ 0.936 ± 0.05, 0.872 ± 0.05, 
0.832 ± 0.04, 0.798 ± 0.04, 0.718 ± 0.03 vs Foxp2S321X/+ 0.983 ± 0.06, 
0.973 ± 0.07, 1.016 ± 0.05, 0.947 ± 0.03, 0.894 ± 0.04. P < 0.001 for 
150, 200, 500 ms, repeated measures ANOVA). Foxp2+/+ N/n = 3/23, 
Foxp2S321X/+ N/n = 3/20. PPR is normalized to the first pulse. f Exam-
ple trace of postsynaptic inhibitory response to forced vesicle exocyto-
sis during 10 s local application of 500 mM sucrose. Scale 2 s/50 pA. 
Normalized (to wild-type) current transfer during 10 s sucrose appli-
cation (Foxp2+/+ = 9.1 × 105 ± 1.26 × 105  pA, Foxp2S321X/+ = 13.4 × 
105 ± 1.6 × 105  pA, P < 0.01, two-sided Students’ T test). Foxp2+/+ 
N/n = 2/15, Foxp2S321X/+ N/n = 3/16. g Example trace of postsynap-
tic response during 10  s local application of 100  µM GABA. Scale 
2 s/200 pA. Quantification of peak amplitude and total current trans-
fer during GABA application (Foxp2+/+ = 1.00 × 103 ± 66.7  pA, Fo
xp2S321X/+ = 1.04 × 103 ± 125  pA, NS, total current transfer Foxp2+/
+ = 4.8 × 106 ± 3.4 × 105  pA, Foxp2S321X/+ = 5.4 × 106 ± 5.5 × 105  pA, 
NS, two-sided Student’s T test). Foxp2+/+ N/n = 2/14,  Foxp2S321X/+ 
N/n = 2/12. *P < 0.05, ***P < 0.001
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0.1 mg/kg PTX injection differentially affected rotarod 
performance of wild-type and Foxp2S321X/+ mice. Both 
wild-type and  Foxp2S321X/+ mice still show an increase 
in performance and a positive learning rate during ses-
sions (Fig. 5c, d). Treatment with PTX had a profound 
negative effect on rotarod performance in Foxp2+/+ mice, 
whilst in Foxp2S321X/+ mice, rotarod performance was 
significantly increased compared to mice without treat-
ment. These opposite effects of PTX treatment resulted in 
a comparable performance of Foxp2+/+ and Foxp2S321X/+ 
mice when comparing average rotarod speed (RPM) at fall 
from the last two trials, (Fig. 5e) with PTX treatment. This 
shows that decreasing inhibitory activity might be a viable 
method to ameliorate motor deficits induced by decreased 
expression of Foxp2 and corroborates our data that in mice 
with reduced Foxp2 expression the E/I balance is shifted 
towards increased inhibition.
Discussion
Mutations in FoxP2 affect striatal circuitry both in human 
cases of speech/language disorder and in animal models of 
Foxp2 dysfunction (Liegeois et al. 2003; Schulz et al. 2010; 
Groszer et al. 2008; French et al. 2012). Here, we show that 
Foxp2 affects both excitatory and inhibitory striatal activity 
in a cell-specific manner during development and in adult-
hood. Foxp2 is predominantly expressed in striatal direct 
pathway D1R-MSNs. Decreased Foxp2 expression leads to 
reduced excitatory activity and increased inhibitory activ-
ity in D1R-MSNs. Molecular evidence suggests that the 
increase in inhibitory activity is due to a de-repression of 
GAD67 expression. The number of GAD67-positive puncta 
around the somata of D1R-MSNs increases when Foxp2 
expression is reduced, which is accompanied by increased 
presynaptic GABA content and increased inhibition of the 
striatal direct pathway. Intriguingly, blocking inhibition with 
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Fig. 5  Pharmacological blockade of inhibition modulates rotarod 
performance and motor skill learning. a Foxp2S321X/+ mice show 
impaired motor skill learning, shown by the decreased latency to fall 
(in seconds) across training sessions (days 1–5: Foxp2+/+ 75.3 ± 9.7, 
120.4 ± 14.4, 164.7 ± 13.6, 165.5 ± 12.2, 160.7 ± 10.8. Foxp2S321X/+ 
34.4 ± 3.1, 52.5 ± 7.4, 53.1 ± 8.7, 55.0 ± 8.15, 82.6 ± 8.38. P < 0.01, 
repeated measured ANOVA). Each session consists of five trials of 
5 min, during which the rotarod accelerated from 4 to 40 rpm. b Both 
Foxp2+/+ and Foxp2S321X/+ mice show a positive learning rate dur-
ing most sessions, with Foxp2+/+ mice having a significantly higher 
learning rate (days 1–5: Foxp2+/+, 10 ± 7.5, 17.8 ± 3.5, 16.3 ± 3.00, 
− 1.4 ± 6.3, 10 ± 2.7. Foxp2S321X/+, 0.9 ± 2.7, 5.7 ± 2.2, − 8.2 ± 1.6, 
3.2 ± 5.6, 8.5 ± 2.2. P < 0.05, repeated measures ANOVA), learning 
rate was calculated as: Learning rate = latency to fall (session 5−session 1)
number of trials
 . 
c, d Foxp2+/+ mice subjected to 0.1  mg/kg intraperitoneal injection 
of PTX show decreased rotarod performance and learning rates, 
whereas these were increased in Foxp2S321X/+ mice (latency to fall: 
days 1–5: Foxp2+/+ 71.7 ± 12.4, 91.7 ± 5.5, 96.4 ± 4.7, 104.4 ± 1.2, 
114 ± 3.2. Foxp2S321X/+ 33.8 ± 4.5, 59.8 ± 5.7, 77.4 ± 5.3, 91.8 ± 1.1, 
103.2 ± 3.61. NS learning rate: Foxp2+/+ 7.2 ± 2.5, 5 ± 2.3, 3.4 ± 1.9, 
− 0.1 ± 4.0, 3.6 ± 3.8. Foxp2S321X/+, 0.76 ± 1.2, 5.9 ± 2.5, 6.4 ± 1.9, 
0.0 ± 1.8, 4.3 ± 3.9. NS, repeated measures ANOVA). e Average RPM 
at which mice fail the accelerating rotarod task during session 4 and 
5 in vehicle and PTX conditions (vehicle, Foxp2+/+ 24.1 ± 0.94 RPM, 
Foxp2S321X/+ 12 ± 0.96 RPM, P < 0.001. PTX, Foxp2+/+ 16.7 ± 0.4 
RPM, Foxp2S321X+ 15.3 ± 0.372 RPM, NS, two-sided Students’ T 
test). For all treatment conditions, N = 5 mice. ***P < 0.001
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PTX results in a partial rescue of motor skill learning deficits 
in Foxp2S321X/+ mice, whereas wild-type littermates show 
impaired motor skill learning after treatment.
Striatal excitatory connections are formed exclusively by 
projections from external sources (Hunnicutt et al. 2016). 
Subpopulations of cortical and thalamic projection neu-
rons form excitatory connections to the striatum (Pan et al. 
2010; Hintiryan et al. 2016), and these brain regions contain 
Foxp2-positive cells as well (Lai et al. 2003; Takahashi et al. 
2003; Vargha-Khadem et al. 2005; Hisaoka et al. 2010; Sia 
et al. 2013). However, it is currently unknown if the cortical 
and thalamic neurons that express Foxp2 project to the stria-
tum. Our data show that reduced Foxp2 expression decreases 
D1R-MSN mEPSC amplitude, without influencing mEPSC 
frequency or excitatory PPR. This suggests that only post-
synaptic excitatory strength is affected, and excitatory inputs 
to the striatum are not affected by reduced Foxp2 expression. 
Furthermore, the lack of excitatory presynaptic changes in 
striatal MSNs indicates that excitatory cortical and thalamic 
cells which do express Foxp2 either do not project to MSNs 
in the dorsolateral striatum or that Foxp2 has no presynaptic 
function in these neurons.
Concurrent with the decrease in excitatory activity, 
we observed an increase in inhibitory activity of striatal 
D1R-MSNs. Gene ontology analysis following Foxp2-
ChIP experiments (Vernes et  al. 2011), which groups 
significantly regulated genes among common biological 
pathways, has suggested GABA signaling pathways are 
regulated by Foxp2. Striatal MSNs express both GAD67 
and GAD65, two catalytic enzymes involved in the produc-
tion of GABA (Laprade and Soghomonian 1999). To our 
knowledge, GAD65 has not been identified as a regulatory 
target of Foxp2, and mRNA levels of Gad2 (the gene which 
codes for GAD65) are unaltered when Foxp2 expression is 
reduced (French et al. 2007). In contrast, the Gad1 gene 
is clearly a regulatory target of Foxp2, shown by ChIP 
(Vernes et al. 2011), and we show that expression of its 
protein product GAD67 is increased around striatal D1R-
MSNs of Foxp2S321X/+ mice. The direct regulation of Gad1 
by Foxp2 suggests Foxp2 expression is necessary to regulate 
GAD67 levels in the striatum. However, we cannot rule out 
that GAD67 levels might be altered in striatal interneurons 
through non-cell autonomous mechanisms dependent on 
Foxp2. Interestingly, increased GAD67 expression levels 
have been causally linked to increased presynaptic GABA 
content (Chao et al. 2010; Hibbert et al. 2004) and enhanced 
GABA transmission (Krishnan et al. 2015), both of which 
occur in D1R-MSNs from Foxp2S321X/+ mice.
Spine formation and excitatory activity in striatal MSNs 
are affected in homozygous Foxp2 knockout mice during 
early postnatal development, possibly through increased 
Mef2C expression. Mef2C is a transcription factor, which 
acts as a developmental brake on glutamatergic synapse 
formation and is regulated by Foxp2 (Chen et al. 2016). 
However, we show that decreased excitatory activity in 
D1R-MSNs is present in both juvenile and adult Foxp2S321X/+ 
mice. Mef2C expression is virtually absent in adolescent 
mouse striatum (Chen et al. 2016). This suggests that the 
decrease in excitatory activity could be caused by impaired 
generation of glutamatergic synapses during early devel-
opment, which can have lasting effects on physiology and 
behavior in adult mice (Harrington et al. 2016). Intriguingly, 
Mef2C, has been shown to regulate the activity of both excit-
atory and inhibitory synapses in cortex in a cell-autonomous 
way (Harrington et al. 2016). Knockout of Mef2C decreased 
excitation and increased inhibition in cortex, similar to the 
physiological changes that we show in striatal D1R-MSNs of 
Foxp2S321X/+ mice. Dysregulation of striatal Mef2C expres-
sion following heterozygous Foxp2 loss of function could, 
therefore, be partially responsible for the striatal E/I imbal-
ance that we measured.
Our findings show that reduced Foxp2 expression disrupts 
striatal E/I balance, which is dynamically regulated through 
pre-and postsynaptic mechanisms (Abbott and Nelson 2000; 
Bolshakov and Siegelbaum 1994; Bi and Poo 1998; Yang 
and Calakos 2013). Whilst the decreased excitatory activity 
seems to originate postsynaptically, our data suggest that 
reduced Foxp2 expression leads to increased presynaptic 
GABA production. D1R-MSNs form extensive connections 
toward the substantia nigra (SN), such that reduced activa-
tion of D1R-MSNs leads to reduced inhibition of the SN. 
Increased release of GABA could be a cell-autonomous 
mechanism to increase the inhibitory drive of D1R-MSN 
projections toward the SN. However, intra-striatal inhibi-
tion is governed by MSNs as well: D1R-MSNs project to 
other D1R-MSNs (Taverna et al. 2008). This means that 
a feedback loop could occur to increase inhibitory drive, 
which would result in stronger inhibition of striatal D1R-
MSNs. Paired recording of striatal D1R-MSNs in Foxp2+/+ 
and Foxp2S321X/+ could help to determine whether such a 
feedback loop is present and if such a mechanism can negate 
the effect of the increased presynaptic GABA production in 
presynaptic terminals within the SN.
Furthermore, the striatal E/I imbalance following reduced 
Foxp2 expression is maintained throughout development and 
in adult mice. This can explain why impaired striatal plastic-
ity and motor skill learning deficits are present in adult mice 
with heterozygous Foxp2 mutations (French et al. 2012; Gro-
szer et al. 2008). Interestingly, in a mouse model for neuroli-
gin-3 (NL-3) dysfunction, known to produce similar behav-
ioral and physiological phenotypes as mutation of Foxp2, 
adult re-expression of NL-3 rescues motor skill learning 
deficits (Rothwell et al. 2014). Restoration of E/I balance 
in adulthood could, therefore, be a viable strategy to ame-
liorate the motor learning deficits observed upon reduced 
Foxp2 expression. Modulation of GABAergic activity using 
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 GABAA antagonists has been shown to improve learning and 
memory in mouse models for cognitive disorders (Rueda 
et al. 2008; Cui et al. 2008) and phase I clinical trials are 
underway to test  GABAA antagonists on people with Down 
syndrome (Contestabile et al. 2017). We show that modu-
lation of GABAergic activity by partially blocking inhibi-
tory activity increases motor skill learning in Foxp2S321X/+ 
mice. Intriguingly, wild-type mice were adversely affected 
by the same PTX treatment, which indicates that success-
ful modulation of GABAergic activity might be highly dose 
dependent.
Taken together, we show for the first time that reduced 
Foxp2 expression bidirectionally affects both excitatory and 
inhibitory activity of striatal direct pathway MSNs, through-
out development as well as in adult mice. Partially blocking 
inhibitory activity in vivo might restore this E/I imbalance, 
and we found that this intervention had a positive effect on 
motor skill learning in mice with reduced Foxp2 expression. 
Restoring the E/I balance by pharmacologically modulating 
inhibitory activity might be a feasible therapeutic interven-
tion for complex motor disorders.
Materials and methods
Mouse lines
The experimental procedures were approved by the Animal 
Ethics Committee of the Radboud University Nijmegen, 
under DEC application number 2014-098 (Nijmegen, The 
Netherlands) and conducted in accordance with the Dutch 
legislation. Every effort was made to minimize animal dis-
comfort and the number of animals used.
The Foxp2-S321X line was maintained on a C57BL/6J 
background, and heterozygotes and wildtype littermates 
between PND11 and PND17 (juvenile) or PND55-65 
(adult) were used for the immunofluorescent stainings and 
electrophysiological recordings. The generation, marker-
assisted backcrossing and genotyping of this strain are fully 
described in (Groszer et al. 2008; Keays et al. 2006; Coghill 
et al. 2002). BACtrap mice carrying GFP under the D1R 
promoter (D1R-GFP) or D2R promoter (D2R-GFP) were 
originally generated by the GENSAT (Gene Expression 
Nervous System Atlas) (Gong et al. 2003) and backcrossed 
to C57BL6/J mice.
Electrophysiology
Experiments were conducted on 350 µm thick coronal slices. 
Mice (PND11-17 or PND55-65) were sacrificed by decapita-
tion following isoflurane anesthesia. Slices were cut using 
a vibratome (HM650V Thermo Scientific) in cooled (4 °C) 
artificial cerebrospinal fluid containing (in mM): 87 NaCl, 
11 Glucose, 75 Sucrose, 2.5 KCl, 1.25  NaH2PO4, 0.5  CaCl2, 
7  MgCl2, 26  NaHCO3, continuously oxygenated with 95% 
 O2/5%  CO2. Collection of slices started when the striatum 
became visible and slices were collected until the hippocam-
pus was visible. After collection, slices were incubated at 
32 °C in oxygenated ACSF for at least 1 h before record-
ing. Slices were transferred to the recording setup 10 min 
prior to recording and incubated in recording ACSF contain-
ing (in mM): 124 NaCl, 3 KCl, 1.25  NaH2PO4, 2  CaCl2, 1 
 MgCl2, 26  NaHCO3, 10 Glucose, continuously oxygenated 
and heated to 32 °C. Patch pipettes (3.5–5.5 MΩ) were made 
from borosilicate glass capillaries and filled with intracellu-
lar solution containing: 115  CsMeSO3; 10 CsCl; 10 HEPES; 
2.5  MgCl2; 4 Na2ATP; 0.4 NaGTP; 10 Na-Phosphocreatine; 
0.6 EGTA, 10 QX-314. Activity was recorded using a 
Digidata 1440A digitizer and a Multiclamp 700B ampli-
fier (Molecular Devices). Sampling rate was set at 20 kHz 
and a lowpass 1 kHz filter was used during recording. All 
recordings were conducted in the dorsolateral quadrant of 
the striatum.
Miniature postsynaptic currents
mEPSCs were recorded in the prescience of Tetrodotoxin 
(TTX, 1 µM, Tocris) and Picrotoxin (PTX, 100 µM, Tocris) 
at a holding voltage of − 60 mV. mIPSCs were recorded in 
the presence of Tetrodotoxin (TTX, 1 µM, Tocris), 6-cyano-
7-nitroquinoxaline-2,3-dione (CNQX, 5 µM, Tocris) and 
(2R)-amino-5-phosphonovaleric acid (APV, 100 µM, Tocris) 
at a holding voltage of + 10 mV.
GABA/AMPA ratio
All stimulation experiments were conducted by stimula-
tion of afferent corticostriatal and intrastriatal axons using 
a bipolar concentric stimulus electrode (FHC, Bowdoin, 
Maine) placed in the dorsolateral striatum. GABA/AMPA 
ratio was measured in the presence of APV (100 µM). Cells 
were voltage-clamped at − 60 mV and a 1 ms stimulus from 
a bipolar tungsten electrode was given to record the AMPA 
response. Subsequently cells were clamped at 0 mV and the 
GABA response was measured.
Paired pulse ratio
Excitatory PPR was measured in the presence of PTX 
(100  µM) and APV (100  µM) with voltage clamped at 
− 60 mV. Inhibitory PPR was measured in the presence of 
CNQX (5 µM) and APV (100 µM) with voltage clamped at 
− 60 mV. Stimulation strength was set to evoke an approx-
imately 200 pA response to the first stimulus. Two 1 ms 
pulses were given with a 50 ms, 100 ms, 150 ms, 200 ms, 
500 ms or 9000 ms (inhibitory PPR only) interval. PPR was 
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calculated as the peak 2/peak 1 ratio after correcting for any 
residual current at the second pulse.
GABA vesicle depletion
One millisecond pulses were given at 10 Hz for 10 s to 
entirely deplete the presynaptic GABA vesicle pool. After 
each 10 s stimulus train, cells were given 0.2 Hz stimulations 
for 40 s to assess the recovery of the vesicle pool between 
each stimulus train. One recording consisted of 10 consecu-
tive stimulus trains. Cells were recorded in the presence of 
CNQX and at a holding voltage of − 60 mV.
Compound application
Sucrose (500 mM) or GABA (20 µM) was applied using 
a pressure ejection system (PDES-2DX, NPI, Tamm, Ger-
many). The injection pressure was set to 5 psi/0.4 bar and 
injection duration was set to 10 s. Interinjection interval was 
set to 1 min. Compounds were delivered using a micropi-
pette positioned at 30 µm from the target cell soma.
Immunofluorescence
Animals were sacrificed by decapitation and whole mouse 
brain was fixed in 4% paraformaldehyde (PFA)/4% sucrose 
for 24 h. 60 µm coronal sections including the striatum were 
cut using a vibratome (Leica VT1000S, Leica microsys-
tems). Slices were transferred to 1x Phosphate buffered 
saline (PBS) for immunofluorescent staining. The following 
antibodies were used: FoxP2 (Santa Cruz Sc-21069, 1:500), 
GAD67 (Millipore MAB5406, 1:200). Imaging was done 
using a Zeiss upright fluorescent microscope with apotome 
(Zeiss Axio Images, Oberkochen, Germany) using a 63 × 
oil immersion objective. For subsequent analysis of immu-
nofluorescent staining, at least four slices per animal were 
analyzed. Data were normalized and average values for each 
animal were taken as the independent variable for further 
statistical analysis. Images were analyzed offline using FIJI 
(Fiji is just imageJ) image analysis software.
Intraperitoneal injection
Foxp2S321X∕+ mice and wild-type littermate controls were 
injected intraperitoneally with either vehicle (DMSO) or 
0.1 mg/kg picrotoxin (Tocris, Bristol, UK). Injection was 
done by hand and mice were placed back in their home cage 
for 10 min following injection, after which mice were placed 
on the accelerating rotarod.
Accelerating rotarod
Foxp2S321X∕+ mice (6–8 weeks old) and wild-type littermate 
controls were placed on an accelerating rotarod (LE8200, 
Harvard apparatus) which increased rotation speed from 4 
to 40 r.p.m. over a 5-min period. Mice were trained for five 
consecutive days, with five trials per day. Latency to fall (in 
seconds or RPM at fall) was scored, and mice were placed 
back in their home cage for 5 min between trials.
Western blot
PND10-15 Foxp2S321X/+ animals and wild-type controls 
were sacrificed by decapitation. The striatum was dissected 
from separated hemispheres, frozen in liquid nitrogen and 
kept at − 80 °C. Samples were homogenized in 200 µl of 
lysis buffer (50 mM Hepes pH 7.4, 140 mM NaCl, 0.1% 
Triton-X100, 1% Tween 20, 0.1% deoxycholate) containing 
protease inhibitor mix (Roche Diagnostics). Protein levels 
were assessed using BCA. Sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (SDS-PAGE) on 10% (w/v) 
at 200V for 30 min was carried out using a Mini-Protean 
system (Bio-Rad, USA). Protein (50 µg) was loaded in each 
lane with loading buffer (0.25 M Tris–HCl, pH 6.8, 2% SDS, 
10% glycerol, 0.25% bromophenolblue, 4% beta-mercaptoe-
thanol). After electrophoresis, proteins were transferred to 
a polyvinylidene fluoride membrane (PVDF, Amersham, 
Hybond-P), using an electrophoretic transfer system (Bio-
Rad, USA). The membranes were then blocked with 5% 
skimmed milk dissolved in TBS-tween 0.1% for 1 h. The 
membranes were incubated overnight at 4 °C with the pri-
mary antibodies diluted in blocking buffer containing 1% 
skimmed milk dissolved in a TBS-Tween. The primary anti-
bodies were the following: mouse monoclonal anti-bodies 
GAD67 (1:1000, Abcam), and GAPDH as a control (1:1000, 
cell signaling). After being washed for 1 h with 1% skimmed 
milk in TBS-T (0.05%), the membranes were incubated for 
1 h in the dark at room temperature with goat-anti-mouse 
secondary antibody (1:5000; Bio-Rad, Goat-anti-mouse 
HRP conjugated). The membranes were imaged using a 
Chemidoc Touch imaging system (Bio-rad, Hercules, CA) 
and the generated pictures were quantified using ImageJ 
software. The levels of protein expression were normalized 
to GAPDH. Protein expression values are normalized to 
Foxp2+/+ expression (relative intensity).
Statistics
Sample size was calculated assuming power of 0.8 and effect 
size d = 0.8, data are acquired from at least three mice for 
each genotype. All data are shown as mean ± SEM. Analysis 
between two groups was done using Students’ T test when 
normally distributed, or Mann–Whitney U rank-sum analysis 
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when data did not pass normality. Analysis between multi-
ple groups using repeated measures ANOVA. All statistical 
analysis was conducted in PRISM (Graphpad PRISM 7.00, 
Graphpad Software, San Diego, CA).
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